Categories: Business

Anlon Healthcare IPO Day 2: The Smart Money Is Moving, Should You Jump In Or Regret It Later?

Anlon Healthcare IPO was open for public subscription on Aug 26 and will close tomorrow Aug 29, targeting to raise ₹121 crore. The IPO priced at ₹86–₹91 per share, offering 1.33 crore shares. The pharma firm supports 50+ countries with API and transitional manufacturing.

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by Ankur Mishra
Last updated: August 28, 2025 15:01:54 IST

Anlon Healthcare Limited has opened its Initial Public Offer on Aug 26, 2025 and will close on Aug 29, 2025. Through this public offer, Alon Healthcare is likely to raise about ₹121 crore over a fresh issue by offering 1.33 crore equity shares.

Anlon Healthcare Limited IPO details at a glance:

• Public Offer Opens: Aug 26, 2025

• Public Offer Closes: Aug 29, 2025

• Size of the IPO: Approx. ₹121 crore

• Price Band: ₹86 ₹91

• Lot Size: 164 equity shares

• Minimum Investment for Retail: Approx. ₹14,104

• Listing At: NSE & BSE

• Registrar: KFin Technologies Limited

Important Dates: Anlon Healthcare Limited IPO

• Bidding for Anchor Investors: Aug 25, 2025

• Finalisation of Basis of Allotment: Sep 01, 2025

• Start of Refunds: Sep 02, 2025

• Credit of Shares to Demat: Sep 02, 2025

• List on Stock Exchange: Sep 03, 2025

Anlon Healthcare Limited IPO has been 2.87 times subscribed. The segment-wise consolidated investors participation are as follows:

• Total Subscription: 2.87x

• Retail Investors: 19.39x

• Qualified Institutional Buyers (QIBs): 0.92x

• Non-Institutional Investors (NIIs): 1.65x

(Data: August 28, 2025 | 14:53)

Anlon Healthcare Limited: Company Overview

Anlon Healthcare Limited is a Rajkot, Gujarat based company dealing in research based pharma company. The company operates in pharmaceutical industry with a focus on manufacturing Active Pharmaceutical Ingredients (APIs) along with Pharmaceutical Intermediates, targeting local and global markets.

The company’s operations are highly organized in pharmaceutical industry, with clients over 50 countries across the Americas, Europe, Africa, Middle East, and Asia.

(Disclaimer: The above article is only for the purpose of information. It does not constitute financial guidance in any form(s). Investors here are suggested to carefully review the prospectus and refer to a registered financial advisor or certified investment professional before they finalise any investment. Similarly, past performances are not an indication of future outcomes. Investments are subject to market risks.)

Also Read: Trade Tensions Aren’t Just Headlines: They Could Cost India, Is Self Reliance An Answer?

Published by Ankur Mishra
Last updated: August 28, 2025 15:01:54 IST

Recent Posts

Putin Commits To Peak Performance At Kudankulam Nuclear Facility, Says ‘Russia Will Be A Reliable Supplier’

Vladimir Putin during his visit to India, announced that the capacity of the Kudankulam Nuclear…

December 5, 2025

Top Opposition Leaders Including Rahul Gandhi, Kharge Not Invited To Presidential Banquet For Putin, But You Might See THIS Congress MP In Attendance

The Congress alleged that Mallikarjun Kharge and Rahul Gandhi were not invited to the Presidential…

December 5, 2025

Redmi Note 15 5G, Note 15 Pro and Note 15 Pro+: Shocking Leaked Price, Expected Specs, Design, Camera, And Everything You Need To Know

Redmi is expected to launch its Note 15 5G series which will have three amazing…

December 5, 2025